TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9321637
log Bayes Factor = 0.157704
Chromosome 6   position 138,266,685  (GRCh37) Explore rs9321637 on Ensembl!
Variant rs9321637 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T39.1 4-Aminophenol derivatives
0.000 0.692 0.308
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.699 0.301
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.709 0.291
T40.2 Other opioids
0.000 0.729 0.271
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.746 0.254
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.755 0.245
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.768 0.231
T39.0 Salicylates
0.000 0.780 0.219
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.784 0.216
T39.4 Antirheumatics, not elsewhere classified
0.000 0.784 0.216
T39.2 Pyrazolone derivatives
0.000 0.784 0.216
T40.4 Other synthetic narcotics
0.000 0.809 0.190
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.810 0.190
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.815 0.185
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.818 0.182
T40.8 Lysergide [LSD]
0.000 0.818 0.182
T40.7 Cannabis (derivatives)
0.000 0.818 0.182
T40.5 Cocaine
0.000 0.818 0.182
T40.3 Methadone
0.000 0.818 0.182
T40.1 Heroin
0.000 0.818 0.182
T40.0 Opium
0.000 0.818 0.182
T36 Poisoning by systemic antibiotics
0.000 0.821 0.179
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.824 0.176
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.824 0.176
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.824 0.176
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.824 0.176
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.837 0.163
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.839 0.161
T45.0 Antiallergic and antiemetic drugs
0.000 0.845 0.155
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.846 0.154
T40.6 Other and unspecified narcotics
0.000 0.853 0.146
T46.1 Calcium-channel blockers
0.000 0.857 0.143
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.862 0.137
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.863 0.137
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.864 0.136
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.864 0.136
T46.7 Peripheral vasodilators
0.000 0.864 0.136
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.864 0.136
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.864 0.136
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.864 0.136
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.867 0.133
T45.8 Other primarily systemic and haematological agents
0.000 0.867 0.133
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.867 0.133
T45.6 Fibrinolysis-affecting drugs
0.000 0.867 0.133
T45.4 Iron and its compounds
0.000 0.867 0.133
T45.3 Enzymes, not elsewhere classified
0.000 0.867 0.133
T45.2 Vitamins, not elsewhere classified
0.000 0.867 0.133
T36.0 Penicillins
0.000 0.868 0.132
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.869 0.131
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.869 0.131
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.871 0.129
T36.9 Systemic antibiotic, unspecified
0.000 0.871 0.128
T36.8 Other systemic antibiotics
0.000 0.871 0.128
T36.7 Antifungal antibiotics, systemically used
0.000 0.871 0.128
T36.6 Rifamycins
0.000 0.871 0.128
T36.5 Aminoglycosides
0.000 0.871 0.128
T36.4 Tetracyclines
0.000 0.871 0.128
T36.3 Macrolides
0.000 0.871 0.128
T36.2 Chloramphenicol group
0.000 0.871 0.128
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.871 0.128
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.873 0.126
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.873 0.126
T37.5 Antiviral drugs
0.000 0.873 0.126
T37.4 Anthelminthics
0.000 0.873 0.126
T37.3 Other antiprotozoal drugs
0.000 0.873 0.126
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.873 0.126
T37.1 Antimycobacterial drugs
0.000 0.873 0.126
T37.0 Sulphonamides
0.000 0.873 0.126
T41.5 Therapeutic gases
0.000 0.873 0.126
T41.4 Anaesthetic, unspecified
0.000 0.873 0.126
T41.3 Local anaesthetics
0.000 0.873 0.126
T41.2 Other and unspecified general anaesthetics
0.000 0.873 0.126
T41.1 Intravenous anaesthetics
0.000 0.873 0.126
T41.0 Inhaled anaesthetics
0.000 0.873 0.126
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.873 0.126
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.873 0.126
T48.5 Anti-common-cold drugs
0.000 0.873 0.126
T48.4 Expectorants
0.000 0.873 0.126
T48.3 Antitussives
0.000 0.873 0.126
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.873 0.126
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.873 0.126
T48.0 Oxytocic drugs
0.000 0.873 0.126
T49.9 Topical agent, unspecified
0.000 0.873 0.126
T49.8 Other topical agents
0.000 0.873 0.126
T49.7 Dental drugs, topically applied
0.000 0.873 0.126
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.873 0.126
T49.5 Ophthalmological drugs and preparations
0.000 0.873 0.126
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.873 0.126
T49.3 Emollients, demulcents and protectants
0.000 0.873 0.126
T49.2 Local astringents and local detergents
0.000 0.873 0.126
T49.1 Antipruritics
0.000 0.873 0.126
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.873 0.126
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.883 0.117
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.883 0.117
T47.7 Emetics
0.000 0.883 0.117
T47.6 Antidiarrhoeal drugs
0.000 0.883 0.117
T47.5 Digestants
0.000 0.883 0.117
T47.4 Other laxatives
0.000 0.883 0.117
T47.3 Saline and osmotic laxatives
0.000 0.883 0.117
T47.2 Stimulant laxatives
0.000 0.883 0.117
T47.0 Histamine H(2)-receptor antagonists
0.000 0.883 0.117
T38.9 Other and unspecified hormone antagonists
0.000 0.884 0.115
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.884 0.115
T38.7 Androgens and anabolic congeners
0.000 0.884 0.115
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.884 0.115
T38.5 Other oestrogens and progestogens
0.000 0.884 0.115
T38.4 Oral contraceptives
0.000 0.884 0.115
T38.2 Antithyroid drugs
0.000 0.884 0.115
T38.1 Thyroid hormones and substitutes
0.000 0.884 0.115
T38.0 Glucocorticoids and synthetic analogues
0.000 0.884 0.115
T45.5 Anticoagulants
0.000 0.886 0.114
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.001 0.891 0.108
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.896 0.104
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.899 0.100
T42.1 Iminostilbenes
0.000 0.901 0.099
T50.8 Diagnostic agents
0.000 0.901 0.099
T50.7 Analeptics and opioid receptor antagonists
0.000 0.901 0.099
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.901 0.099
T50.5 Appetite depressants
0.000 0.901 0.099
T50.4 Drugs affecting uric acid metabolism
0.000 0.901 0.099
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.901 0.099
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.901 0.099
T50.1 Loop [high-ceiling] diuretics
0.000 0.901 0.099
T50.0 Mineralocorticoids and their antagonists
0.000 0.901 0.099
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.902 0.098
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.902 0.098
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.902 0.098
T42.3 Barbiturates
0.000 0.902 0.098
T42.2 Succinimides and oxazolidinediones
0.000 0.902 0.098
T42.0 Hydantoin derivatives
0.000 0.902 0.098
T42.4 Benzodiazepines
0.000 0.907 0.093
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.913 0.087
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.001 0.922 0.078
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.001 0.922 0.078
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.001 0.922 0.078
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.001 0.922 0.078
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.001 0.922 0.078
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.001 0.922 0.078
T44.1 Other parasympathomimetics [cholinergics]
0.001 0.922 0.078
T44.0 Anticholinesterase agents
0.001 0.922 0.078
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.933 0.067
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.933 0.067
T43.9 Psychotropic drug, unspecified
0.000 0.937 0.063
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.937 0.063
T43.6 Psychostimulants with abuse potential
0.000 0.937 0.063
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.937 0.063
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.001 0.940 0.060
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.940 0.060
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.943 0.057
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.946 0.054
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.001 0.953 0.046
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.956 0.044
T43.2 Other and unspecified antidepressants
0.000 0.960 0.040
J45.9 Asthma, unspecified
0.000 0.967 0.033
D12.2 Ascending colon
0.000 0.971 0.029
D12.4 Descending colon
0.000 0.982 0.018
J33.9 Nasal polyp, unspecified
0.000 0.985 0.015
O48 Prolonged pregnancy
0.000 0.985 0.015
J45 Asthma
0.000 0.988 0.012
D12 Benign neoplasm of colon, rectum, anus and anal canal
0.000 0.988 0.012
I44.7 Left bundle-branch block, unspecified
0.010 0.990 0.000
D12.1 Appendix
0.000 0.991 0.009
I44.1 Atrioventricular block, second degree
0.009 0.991 0.000
D12.3 Transverse colon
0.000 0.991 0.009
J45.8 Mixed asthma
0.000 0.991 0.008
J45.1 Nonallergic asthma
0.000 0.991 0.008
Z92.6 Personal history of chemotherapy for neoplastic disease
0.000 0.991 0.009
I44 Atrioventricular and left bundle-branch block
0.008 0.992 0.000
D12.7 Rectosigmoid junction
0.000 0.992 0.008
D12.9 Anus and anal canal
0.000 0.992 0.008
I44.2 Atrioventricular block, complete
0.007 0.993 0.000
J45.0 Predominantly allergic asthma
0.000 0.994 0.006
I44.6 Other and unspecified fascicular block
0.006 0.994 0.000
I44.5 Left posterior fascicular block
0.006 0.994 0.000
I44.4 Left anterior fascicular block
0.006 0.994 0.000
I44.0 Atrioventricular block, first degree
0.006 0.994 0.000
Z96.0 Presence of urogenital implants
0.000 0.995 0.005
J44.8 Other specified chronic obstructive pulmonary disease
0.000 0.995 0.005
L57.0 Actinic keratosis
0.005 0.995 0.000
I44.3 Other and unspecified atrioventricular block
0.005 0.995 0.000
D12.6 Colon, unspecified
0.000 0.995 0.005
D12.0 Caecum
0.000 0.996 0.004
E87.1 Hypo-osmolality and hyponatraemia
0.000 0.996 0.004
A08.4 Viral intestinal infection, unspecified
0.004 0.996 0.000
M41.99 Scoliosis, unspecified (Site unspecified)
0.000 0.996 0.004
E21.3 Hyperparathyroidism, unspecified
0.000 0.996 0.004
H43.8 Other disorders of vitreous body
0.000 0.996 0.004
C79.9 Secondary malignant neoplasm, unspecified site
0.000 0.996 0.004
N13.3 Other and unspecified hydronephrosis
0.000 0.996 0.004
J33 Nasal polyp
0.000 0.996 0.004
D12.8 Rectum
0.000 0.996 0.004
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.000 0.996 0.004
C79 Secondary malignant neoplasm of other sites
0.000 0.997 0.003
C62.9 Testis, unspecified
0.000 0.997 0.003
O14.9 Preeclampsia, unspecified
0.000 0.997 0.003
Y52.3 Coronary vasodilators, not elsewhere classified
0.000 0.997 0.003
K70.9 Alcoholic liver disease, unspecified
0.000 0.997 0.003
M35.3 Polymyalgia rheumatica
0.003 0.997 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.000 0.997 0.003
C79.2 Secondary malignant neoplasm of skin
0.000 0.997 0.003
M41.96 Scoliosis, unspecified (Lumbar region)
0.000 0.997 0.003
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.000 0.997 0.003
J33.0 Polyp of nasal cavity
0.000 0.997 0.003
M07.30 Other psoriatic arthropathies (Multiple sites)
0.003 0.997 0.000
M41.9 Scoliosis, unspecified
0.000 0.997 0.003
J33.1 Polypoid sinus degeneration
0.000 0.997 0.003
Q63.0 Accessory kidney
0.003 0.997 0.000
L57 Skin changes due to chronic exposure to nonionising radiation
0.003 0.997 0.000
K70.1 Alcoholic hepatitis
0.000 0.997 0.003
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.997 0.003
I26.9 Pulmonary embolism without mention of acute cor pulmonale
0.000 0.997 0.003
Z73.9 Problem related to life-management difficulty, unspecified
0.000 0.997 0.003
G12.2 Motor neuron disease
0.000 0.997 0.003
Y52 Agents primarily affecting the cardiovascular system
0.000 0.997 0.003
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.000 0.997 0.003
A08 Viral and other specified intestinal infections
0.003 0.997 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.997 0.002
K70 Alcoholic liver disease
0.000 0.997 0.003
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.000 0.997 0.002
C79.6 Secondary malignant neoplasm of ovary
0.000 0.998 0.002
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)
0.000 0.998 0.002
M41.97 Scoliosis, unspecified (Lumbosacral region)
0.000 0.998 0.002
M41.93 Scoliosis, unspecified (Cervicothoracic region)
0.000 0.998 0.002
M41.92 Scoliosis, unspecified (Cervical region)
0.000 0.998 0.002
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)
0.000 0.998 0.002
M41.90 Scoliosis, unspecified (Multiple sites in spine)
0.000 0.998 0.002
Z73.3 Stress, not elsewhere classified
0.000 0.998 0.002
Q63 Other congenital malformations of kidney
0.002 0.998 0.000
D07.5 Prostate
0.000 0.998 0.002
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified
0.002 0.998 0.000
L57.5 Actinic granuloma
0.002 0.998 0.000
L57.3 Poikiloderma of Civatte
0.002 0.998 0.000
L57.2 Cutis rhomboidalis nuchae
0.002 0.998 0.000
L57.1 Actinic reticuloid
0.002 0.998 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.002 0.998 0.000
M41.94 Scoliosis, unspecified (Thoracic region)
0.000 0.998 0.002
Q25 Congenital malformations of great arteries
0.002 0.998 0.000
G58.9 Mononeuropathy, unspecified
0.000 0.998 0.002
M07.3 Other psoriatic arthropathies
0.002 0.998 0.000
Q25.6 Stenosis of pulmonary artery
0.002 0.998 0.000
Q25.0 Patent ductus arteriosus
0.002 0.998 0.000
K70.4 Alcoholic hepatic failure
0.000 0.998 0.002
M07.34 Other psoriatic arthropathies (Hand)
0.002 0.998 0.000
A08.1 Acute gastro-enteropathy due to Norwalk agent
0.002 0.998 0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation
0.002 0.998 0.000
L57.4 Cutis laxa senilis
0.002 0.998 0.000
M41.95 Scoliosis, unspecified (Thoracolumbar region)
0.000 0.998 0.002
J42 Unspecified chronic bronchitis
0.000 0.998 0.002
E87.3 Alkalosis
0.000 0.998 0.002
E87.6 Hypokalaemia
0.000 0.998 0.002
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.998 0.002
R90.0 Intracranial space-occupying lesion
0.002 0.998 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.998 0.002
Y52.8 Antivaricose drugs, including sclerosing agents
0.000 0.998 0.002
Y52.7 Peripheral vasodilators
0.000 0.998 0.002
Y52.1 Calcium-channel blockers
0.000 0.998 0.002
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.998 0.002
Z73 Problems related to life-management difficulty
0.000 0.998 0.002
M80.10 Postoophorectomy osteoporosis with pathological fracture (Multiple sites)
0.002 0.998 0.000
R76.8 Other specified abnormal immunological findings in serum
0.002 0.998 0.000
A08.5 Other specified intestinal infections
0.002 0.998 0.000
A08.3 Other viral enteritis
0.002 0.998 0.000
A08.2 Adenoviral enteritis
0.002 0.998 0.000
A08.0 Rotaviral enteritis
0.002 0.998 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.000 0.998 0.002
C79.7 Secondary malignant neoplasm of adrenal gland
0.000 0.998 0.002
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
0.000 0.998 0.002
K70.2 Alcoholic fibrosis and sclerosis of liver
0.000 0.998 0.002
R09.0 Asphyxia
0.000 0.998 0.002
Q27 Other congenital malformations of peripheral vascular system
0.002 0.998 0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)
0.002 0.998 0.000
Q20-Q28 Congenital malformations of the circulatory system
0.002 0.998 0.000
Q27.3 Peripheral arteriovenous malformation
0.002 0.998 0.000
E87 Other disorders of fluid, electrolyte and acid-base balance
0.000 0.998 0.002
K02.9 Dental caries, unspecified
0.002 0.998 0.000
Q63.9 Congenital malformation of kidney, unspecified
0.002 0.998 0.000
Q63.8 Other specified congenital malformations of kidney
0.002 0.998 0.000
Q63.3 Hyperplastic and giant kidney
0.002 0.998 0.000
Q63.2 Ectopic kidney
0.002 0.998 0.000
Q60-Q64 Congenital malformations of the urinary system
0.002 0.998 0.000
Q25.9 Congenital malformation of great arteries, unspecified
0.002 0.998 0.000
Q25.8 Other congenital malformations of great arteries
0.002 0.998 0.000
Q25.7 Other congenital malformations of pulmonary artery
0.002 0.998 0.000
Q25.5 Atresia of pulmonary artery
0.002 0.998 0.000
Q25.4 Other congenital malformations of aorta
0.002 0.998 0.000
Q25.3 Stenosis of aorta
0.002 0.998 0.000
Q25.2 Atresia of aorta
0.002 0.998 0.000
Q25.1 Coarctation of aorta
0.002 0.998 0.000
Q63.1 Lobulated, fused and horseshoe kidney
0.002 0.998 0.000
R19.0 Intra-abdominal and pelvic swelling, mass and lump
0.000 0.998 0.002
M07.38 Other psoriatic arthropathies (Other)
0.002 0.998 0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)
0.002 0.998 0.000
M07.33 Other psoriatic arthropathies (Forearm)
0.002 0.998 0.000
M07.32 Other psoriatic arthropathies (Upper arm)
0.002 0.998 0.000
M07.31 Other psoriatic arthropathies (Shoulder region)
0.002 0.998 0.000
M07.39 Other psoriatic arthropathies (Site unspecified)
0.002 0.998 0.000
Q28 Other congenital malformations of circulatory system
0.002 0.998 0.000
E07.9 Disorder of thyroid, unspecified
0.002 0.998 0.000
J40-J47 Chronic lower respiratory diseases
0.000 0.998 0.002
Q27.8 Other specified congenital malformations of peripheral vascular system
0.002 0.998 0.000
L53.8 Other specified erythematous conditions
0.002 0.998 0.000
Q61.5 Medullary cystic kidney
0.002 0.998 0.000
Q61.3 Polycystic kidney, unspecified
0.002 0.998 0.000
Z11.0 Special screening examination for intestinal infectious diseases
0.000 0.998 0.002
Q28.2 Arteriovenous malformation of cerebral vessels
0.002 0.998 0.000
Q61 Cystic kidney disease
0.002 0.998 0.000
M07.36 Other psoriatic arthropathies (Lower leg)
0.002 0.998 0.000
Z73.5 Social role conflict, not elsewhere classified
0.000 0.998 0.002
Z73.4 Inadequate social skills, not elsewhere classified
0.000 0.998 0.002
Z73.2 Lack of relaxation and leisure
0.000 0.998 0.002
Z73.1 Accentuation of personality traits
0.000 0.998 0.002
Z73.0 Burn-out
0.000 0.998 0.002
K70.3 Alcoholic cirrhosis of liver
0.000 0.998 0.002
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.998 0.002
G12 Spinal muscular atrophy and related syndromes
0.000 0.998 0.002
Q24 Other congenital malformations of heart
0.002 0.998 0.000
Q27.9 Congenital malformation of peripheral vascular system, unspecified
0.002 0.998 0.000
Q27.4 Congenital phlebectasia
0.002 0.998 0.000
Q27.2 Other congenital malformations of renal artery
0.002 0.998 0.000
Q27.1 Congenital renal artery stenosis
0.002 0.998 0.000
Q27.0 Congenital absence and hypoplasia of umbilical artery
0.002 0.998 0.000
R72 Abnormality of white blood cells, not elsewhere classified
0.002 0.998 0.000
E87.2 Acidosis
0.000 0.998 0.002
O04.4 Incomplete, without complication
0.002 0.998 0.000
Q26 Congenital malformations of great veins
0.002 0.998 0.000
Q22 Congenital malformations of pulmonary and tricuspid valves
0.002 0.998 0.000
Q20 Congenital malformations of cardiac chambers and connexions
0.002 0.998 0.000
R76 Other abnormal immunological findings in serum
0.002 0.998 0.000
Q61.9 Cystic kidney disease, unspecified
0.002 0.998 0.000
Z73.6 Limitation of activities due to disability
0.000 0.998 0.002
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter
0.002 0.998 0.000
E87.4 Mixed disorder of acid-base balance
0.000 0.998 0.002
K92.0 Haematemesis
0.000 0.998 0.002
Z92.8 Personal history of other medical treatment
0.000 0.998 0.002
K70.0 Alcoholic fatty liver
0.000 0.998 0.002
Q28.9 Congenital malformation of circulatory system, unspecified
0.001 0.998 0.000
Q28.8 Other specified congenital malformations of circulatory system
0.001 0.998 0.000
Q28.3 Other malformations of cerebral vessels
0.001 0.998 0.000
Q28.1 Other malformations of precerebral vessels
0.001 0.998 0.000
Q28.0 Arteriovenous malformation of precerebral vessels
0.001 0.998 0.000
R50.9 Fever, unspecified
0.000 0.998 0.002
R73.0 Abnormal glucose tolerance test
0.002 0.998 0.000
Z73.8 Other problems related to life-management difficulty
0.000 0.998 0.002
J41 Simple and mucopurulent chronic bronchitis
0.000 0.998 0.002
Q60 Renal agenesis and other reduction defects of kidney
0.002 0.998 0.000
S22.30 Fracture of rib (closed)
0.000 0.998 0.002
Q64 Other congenital malformations of urinary system
0.001 0.998 0.000
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified
0.000 0.998 0.002
C62 Malignant neoplasm of testis
0.000 0.998 0.002
Q61.8 Other cystic kidney diseases
0.001 0.998 0.000
Q61.4 Renal dysplasia
0.001 0.998 0.000
Q61.1 Polycystic kidney, infantile type
0.001 0.998 0.000
S22.00 Fracture of thoracic vertebra (closed)
0.000 0.998 0.002
Q15.0 Congenital glaucoma
0.001 0.998 0.000
Q24.9 Congenital malformation of the heart, unspecified
0.001 0.998 0.000
X62.9 Unspecified place
0.000 0.998 0.002
E21.0 Primary hyperparathyroidism
0.000 0.998 0.002
Z71.3 Dietary counselling and surveillance
0.000 0.998 0.002
M41 Scoliosis
0.000 0.998 0.002
M24.54 Contracture of joint (Hand)
0.002 0.998 0.000
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.998 0.001
E21.4 Other specified disorders of parathyroid gland
0.000 0.998 0.001
E21.2 Other hyperparathyroidism
0.000 0.998 0.001
E87.0 Hyperosmolality and hypernatraemia
0.000 0.998 0.002
R45.8 Other symptoms and signs involving emotional state
0.000 0.998 0.002
R70.0 Elevated erythrocyte sedimentation rate
0.001 0.998 0.000
Q21 Congenital malformations of cardiac septa
0.001 0.998 0.000
G12.9 Spinal muscular atrophy, unspecified
0.000 0.998 0.001
G12.8 Other spinal muscular atrophies and related syndromes
0.000 0.998 0.001
G12.1 Other inherited spinal muscular atrophy
0.000 0.998 0.001
G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]
0.000 0.998 0.001
M31.6 Other giant cell arteritis
0.000 0.998 0.002
Q24.6 Congenital heart block
0.001 0.998 0.000
Q24.4 Congenital subaortic stenosis
0.001 0.998 0.000
Q24.3 Pulmonary infundibular stenosis
0.001 0.998 0.000
Q24.2 Cor triatriatum
0.001 0.998 0.000
Q24.1 Levocardia
0.001 0.998 0.000
Q24.0 Dextrocardia
0.001 0.998 0.000
Q62.5 Duplication of ureter
0.001 0.998 0.000
L53 Other erythematous conditions
0.002 0.998 0.000
Q23 Congenital malformations of aortic and mitral valves
0.001 0.998 0.000
M24.47 Recurrent dislocation and subluxation of joint (Ankle and foot)
0.001 0.998 0.000
Q24.8 Other specified congenital malformations of heart
0.001 0.998 0.000
Q24.5 Malformation of coronary vessels
0.001 0.998 0.000
R76.9 Abnormal immunological finding in serum, unspecified
0.001 0.998 0.000
R76.2 False-positive serological test for syphilis
0.001 0.998 0.000
R76.1 Abnormal reaction to tuberculin test
0.001 0.998 0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system
0.002 0.998 0.000
M24.26 Disorder of ligament (Lower leg)
0.001 0.998 0.000
Q20.9 Congenital malformation of cardiac chambers and connexions, unspecified
0.001 0.998 0.000
Q20.8 Other congenital malformations of cardiac chambers and connexions
0.001 0.998 0.000
Q20.6 Isomerism of atrial appendages
0.001 0.998 0.000
Q20.5 Discordant atrioventricular connexion
0.001 0.998 0.000
Q20.4 Double inlet ventricle
0.001 0.998 0.000
Q20.3 Discordant ventriculoarterial connexion
0.001 0.998 0.000
Q20.2 Double outlet left ventricle
0.001 0.998 0.000
Q20.1 Double outlet right ventricle
0.001 0.998 0.000
Q20.0 Common arterial trunk
0.001 0.998 0.000
Q22.9 Congenital malformation of tricuspid valve, unspecified
0.001 0.998 0.000
Q22.8 Other congenital malformations of tricuspid valve
0.001 0.998 0.000
Q22.6 Hypoplastic right heart syndrome
0.001 0.998 0.000
Q22.5 Ebstein's anomaly
0.001 0.998 0.000
Q22.4 Congenital tricuspid stenosis
0.001 0.998 0.000
Q22.3 Other congenital malformations of pulmonary valve
0.001 0.998 0.000
Q22.2 Congenital pulmonary valve insufficiency
0.001 0.998 0.000
Q22.1 Congenital pulmonary valve stenosis
0.001 0.998 0.000
Q22.0 Pulmonary valve atresia
0.001 0.998 0.000
Q26.9 Congenital malformation of great vein, unspecified
0.001 0.998 0.000
Q26.8 Other congenital malformations of great veins
0.001 0.998 0.000
Q26.6 Portal vein-hepatic artery fistula
0.001 0.998 0.000
Q26.5 Anomalous portal venous connexion
0.001 0.998 0.000
Q26.4 Anomalous pulmonary venous connexion, unspecified
0.001 0.998 0.000
Q26.3 Partial anomalous pulmonary venous connexion
0.001 0.998 0.000
Q26.2 Total anomalous pulmonary venous connexion
0.001 0.998 0.000
Q26.1 Persistent left superior vena cava
0.001 0.998 0.000
Q26.0 Congenital stenosis of vena cava
0.001 0.998 0.000
Q62.8 Other congenital malformations of ureter
0.001 0.998 0.000
Q62.7 Congenital vesico-uretero-renal reflux
0.001 0.998 0.000
Q62.6 Malposition of ureter
0.001 0.998 0.000
Q62.4 Agenesis of ureter
0.001 0.998 0.000
Q62.3 Other obstructive defects of renal pelvis and ureter
0.001 0.998 0.000
Q62.2 Congenital megaloureter
0.001 0.998 0.000
Q62.1 Atresia and stenosis of ureter
0.001 0.998 0.000
Q62.0 Congenital hydronephrosis
0.001 0.998 0.000
Q78.0 Osteogenesis imperfecta
0.001 0.998 0.000
L52 Erythema nodosum
0.001 0.998 0.000
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria
0.000 0.998 0.001
Q78 Other osteochondrodysplasias
0.001 0.998 0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue
0.001 0.998 0.000
Q23.0 Congenital stenosis of aortic valve
0.001 0.998 0.000
Q60.0 Renal agenesis, unilateral
0.001 0.998 0.000
R76.0 Raised antibody titer
0.001 0.998 0.000
J40 Bronchitis, not specified as acute or chronic
0.000 0.998 0.001
Q15 Other congenital malformations of eye
0.001 0.998 0.000
Q74 Other congenital malformations of limb(s)
0.001 0.998 0.000
R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity
0.001 0.998 0.000
Z92 Personal history of medical treatment
0.000 0.998 0.002
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.999 0.001
N42.8 Other specified disorders of prostate
0.000 0.999 0.001
N42.2 Atrophy of prostate
0.000 0.999 0.001
Q60.6 Potter's syndrome
0.001 0.999 0.000
Q60.5 Renal hypoplasia, unspecified
0.001 0.999 0.000
Q60.4 Renal hypoplasia, bilateral
0.001 0.999 0.000
Q60.3 Renal hypoplasia, unilateral
0.001 0.999 0.000
Q60.1 Renal agenesis, bilateral
0.001 0.999 0.000
Z92.3 Personal history of irradiation
0.000 0.999 0.001
J44 Other chronic obstructive pulmonary disease
0.000 0.999 0.001
L56 Other acute skin changes due to ultraviolet radiation
0.001 0.999 0.000
M24.51 Contracture of joint (Shoulder region)
0.001 0.999 0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis
0.000 0.999 0.001
J41.1 Mucopurulent chronic bronchitis
0.000 0.999 0.001
J41.0 Simple chronic bronchitis
0.000 0.999 0.001
Q61.2 Polycystic kidney, adult type
0.001 0.999 0.000
Q64.9 Congenital malformation of urinary system, unspecified
0.001 0.999 0.000
Q64.8 Other specified congenital malformations of urinary system
0.001 0.999 0.000
Q64.7 Other congenital malformations of bladder and urethra
0.001 0.999 0.000
Q64.6 Congenital diverticulum of bladder
0.001 0.999 0.000
Q64.5 Congenital absence of bladder and urethra
0.001 0.999 0.000
Q64.4 Malformation of urachus
0.001 0.999 0.000
Q64.2 Congenital posterior urethral valves
0.001 0.999 0.000
Q64.1 Exstrophy of urinary bladder
0.001 0.999 0.000
Q64.0 Epispadias
0.001 0.999 0.000
Q74.0 Other congenital malformations of upper limb(s), including shoulder girdle
0.001 0.999 0.000
C62.1 Descended testis
0.000 0.999 0.001
C62.0 Undescended testis
0.000 0.999 0.001
L56.9 Acute skin change due to ultraviolet radiation, unspecified
0.001 0.999 0.000
O14.1 Severe preeclampsia
0.000 0.999 0.001
T78.1 Other adverse food reactions, not elsewhere classified
0.001 0.999 0.000
M13.97 Arthritis, unspecified (Ankle and foot)
0.001 0.999 0.000
L73.9 Follicular disorder, unspecified
0.000 0.999 0.001
R77.8 Other specified abnormalities of plasma proteins
0.001 0.999 0.000
T21.3 Burn of third degree of trunk
0.001 0.999 0.000
Q65 Congenital deformities of hip
0.001 0.999 0.000
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified
0.000 0.999 0.001
R70-R79 Abnormal findings on examination of blood, without diagnosis
0.001 0.999 0.000
M41.5 Other secondary scoliosis
0.000 0.999 0.001
M41.4 Neuromuscular scoliosis
0.000 0.999 0.001
M41.3 Thoracogenic scoliosis
0.000 0.999 0.001
M41.2 Other idiopathic scoliosis
0.000 0.999 0.001
M41.1 Juvenile idiopathic scoliosis
0.000 0.999 0.001
M41.0 Infantile idiopathic scoliosis
0.000 0.999 0.001
Q38.7 Pharyngeal pouch
0.000 0.999 0.001
Q76 Congenital malformations of spine and bony thorax
0.001 0.999 0.000
D23.6 Skin of upper limb, including shoulder
0.000 0.999 0.001
L53.3 Other chronic figurate erythema
0.001 0.999 0.000
L53.2 Erythema marginatum
0.001 0.999 0.000
L53.1 Erythema annulare centrifugum
0.001 0.999 0.000
L53.0 Toxic erythema
0.001 0.999 0.000
Q21.9 Congenital malformation of cardiac septum, unspecified
0.001 0.999 0.000
Q21.8 Other congenital malformations of cardiac septa
0.001 0.999 0.000
Q21.4 Aortopulmonary septal defect
0.001 0.999 0.000
Q21.3 Tetralogy of Fallot
0.001 0.999 0.000
Q21.2 Atrioventricular septal defect
0.001 0.999 0.000
Q21.1 Atrial septal defect
0.001 0.999 0.000
Q64.3 Other atresia and stenosis of urethra and bladder neck
0.001 0.999 0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck
0.001 0.999 0.000
M24.75 Protrusio acetabuli-Pelvic/thigh
0.001 0.999 0.000
L50.9 Urticaria, unspecified
0.001 0.999 0.000
N42.9 Disorder of prostate, unspecified
0.000 0.999 0.001
Q23.9 Congenital malformation of aortic and mitral valves, unspecified
0.001 0.999 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.